IAMRA's strategic priorities include regulatory thought leadership and supporting members in navigating emerging technologies. The AI Working Group is a Board-appointed working group that provides expert advice and recommendations on the ethical use of artificial intelligence in healthcare and medical regulation, and develops guidance to support regulators in addressing AI-related opportunities and challenges. (see full Charter).
Members of the AI Working Group
Dr. Muhannad Almughthim Mr. Daniel Harris Dr. Neeraj Mahboobani Mr. Frank Meyers | Mr. Muhammad Mudaasar Ms. Josephine Mwakutuya Dr. Werner Oberholzer Dr. Dion Richetti |